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i) blood cultures: Gram-positive 51%, Gram-negative 44%, mixed
5%, fungi 0%; ii) Septifast: Gram-positive 27%, Gram-negative 59%,
mixed 8%, fungi 6%. Using blood cultures as reference, sensitiv-
ity of Septifast PCR was 38% (13% in Gram-positive, 57% in Gram-
negative), specificity 64%, PPV 26%, NPV 76%. 39% of pathogens
not detected by Septifast were not included in the test spec-
trum. Performance of blood cultures and Septifast PCR in differ-
ent settings are shown in the table. Microbiological documenta-
tion was obtained by Septifast PCR in 29/98 (30%) blood culture-
negative episodes: 19/51 (37%) CDI and 10/44 (23%) FUO. 19/23
(83%) pathogens identified by Septifast in CDI were consistent with
the site of infection. Fungi were detected in 5 blood cultures-
negative episodes of probable or possible invasive mycoses (Can-
dida 4, Aspergillus 1).
Positive Positive P value
blood cultures Septifast PCR
No antibacterial therapy (n=93) 27 (29%)* 19 (20%)** 0.23
Antibacterial therapy (n=144) 13 (9%)* 42 (29%)** <0.001
Onset of fever, D1 (n=49) 9 (18%) 17 (35%) 0.11
Persistent fever, D3 (n=95) 4 (4%) 25 (26%) <0.001
*P<0.001, **P=0.17.
Conclusions: Septifast PCR is a promising additional tool for the
microbiological documentation of blood culture-negative febrile
neutropenic episodes. Septifast may be particularly useful in pa-
tients receiving antibiotics at time of blood sampling or with per-
sistent fever.
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Background: Invasive Fungal Infections (IFI) are life-threatening
complications in neutropenic patients with Acute leukemia (AL).
The diagnosis of IFI is challenging because of the lack of specificity
of clinical signs and the low sensitivity of cultures. This results in a
large empirical use of antifungal agents. Septifast (Roche), a new
PCR-based blood assay for detection of bacterial and fungal DNA
in patients with sepsis, may contribute to the early diagnosis of IFI
during neutropenia.
Objective: To assess the efficiency of Septifast PCR for the diag-
nosis of IFI in neutropenic patients with AL.
Method: Pilot observational prospective study. Blood samples for
Septifast PCR were drawn in adult febrile neutropenic patients
with AL at onset of fever and twice weekly during persistent fever.
IFI were classified as proven, probable or possible according to the
EORTC-MSG criteria. The efficiency of Septifast PCR for the diagno-
sis of IFI was compared to that of clinical assessment (EORTC-MSG
criteria).
Results: One hundred and three samples were analyzed during 65
febrile episodes in 34 patients. 7 (11%) episodes were classified
as probable or possible IFI (3 probable candidiasis, 2 probable as-
pergillosis, 2 possible IFI). No fungemia was detected by blood cul-
tures. Septifast PCR detected fungi in 6 febrile episodes as shown
in the table. Using EORTC-MSG criteria as gold standard for the di-
agnosis of IFI, sensitivity of Septifast PCR was 71%, specificity 98%,
PPV 83%, NPV 97% and efficiency 95%. Septfiast PCR positivity pre-
ceded the diagnosis of IFI by EORTC-MSG criteria in 3/4 cases and
start of empirical antifungal therapy in 1/4 cases.
Detection by Septifast PCR EORTC-MSG criteria
Probable IFI Possible IFI No IFI
Candida spp. (n=5) 3 1 1
C. albicans (n=3) 2 1 –
C. tropicalis (n=2) 1 – 1
Aspergillus spp. (n=1) – 1 –
A. fumigatus (n=1) – 1 –
No pathogen 2* – –
*Probable pulmonary aspergillosis (positive CT-Scan + galactomannan in
BAL).
Conclusions: This pilot study suggests that Septifast PCR blood as-
say may be an efficient tool for the early diagnosis of invasive
mycoses in neutropenic patients with acute leukemia. Excellent
test' s specificity and negative predictive value might contribute to
targeted use of antifungal therapy.
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Objectives: The pattern of infections in neutropenic patients is
changing over time along with our clinical practices and antibi-
otic usage. A prospective observational multicenter study was con-
ducted to record the type and frequency of infections in neu-
tropenic patients with haematological malignancies.
Patients and Methods: The study was conducted between May
2007 and September 2007 in seven tertiary care hospitals located
in different geographic compartments of Greece. Eligible were all
the patients with haematological malignancy and chemotherapy-
induced neutropenia (neutrophil count <500/mm3). Pertinent in-
formation regarding patients' demographic characteristics, under-
lying disease, therapeutic modalities, duration of neutropenia, and
clinical course was abstracted in a pre-designed form.
Results: Three hundred and two patients were enrolled in the
study; 156 males and 146 females with median age 50 years (0.2
to 88 years). Sixty-three patients had ALL, 117 AML, 2 CLL, 2 CML,
1 MDS, 27 MM, 62 NHL and 28 HD. Twenty-five patients had under-
gone allogeneic bone marrow transplantation and 45 autologous.
Ninety-three patients (31%) had long-lasting central vein catheter
(CVC). The median duration of neutropenia was 9 days (1 to 57
days) with a median nadir of 80/mm3 (0 to 500). Two hundred and
thirty patients (74%) developed fever during neutropenia. Pres-
ence of CVC, duration, and depth of neutropenia were indepen-
dent risk factors for a febrile episode. In 137 patients (59.6%)
the fever was attributed to infection, whereas in the remaining
93 febrile patients (40.4%) no causative agent was identified. The
isolated organisms and the source of isolation are shown in Ta-
ble 1.
One hundred and twenty-seven courses of anti-fungal treatment
were given, of which 71 on empiric basis. Twenty-one of 230 (9.1%)
febrile patients died because of infection.
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Table 1
Blood Urine Sputum Other Total(%)
Gram-positive 49 8 11 33 101 (45.4)
Gram-negative 43 25 12 20 100 (44.9)
Fungi 6 – 9 7 22 (9.7)
Total 98 33 32 60 223 (100)
Conclusions: Fever constitutes a frequent complication in neu-
tropenic patients with haematological malignancies and in approx-
imately 60% of febrile episodes a causative organism is identi-
fied. An equal number of infections are caused by Gram-positive
and Gram-negative organisms. In more than half of the cases the
anti-fungal treatment is given empirically. The infection-attributed
mortality is 9.1%.
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Background: Patients treated in ICU often suffer from malignan-
cies. Infections are among the most frequent complications occur-
ring in cancer patients undergoing antineoplastic chemo- or im-
munotherapy.
Objectives: The aim of this study was to investigate the preva-
lence of ICU- acquired infections these patients suffer from after
a surgical operation or an immunosupressive treatment.
Methods: Twenty-four patients suffering from malignancies (Ca,
lymphomas, multiple myeloma, etc.) were admitted to the ICU
during the last two years. Clinical samples (blood, urine, central
venous catheter, drainage, bronchial lavage etc.) were obtained
from 13 of them. Specimens were inoculated and incubated ac-
cording to standard bacteriological methods. Identification and
susceptibility testing of culture isolates was performed by VITEK
semi-automatic system in accordance with the CLSI guidelines.
Results: Pathogens were isolated in 11 of 13 patients (84.6%). One
to five pathogens were isolated in each patient. 13 of them were
Gram-positive bacteria (25%), 8 were Gram-negative bacteria (32%)
and 4 were Candida spp (16%). Pathogens detected are presented
in the table:
Table 1. Microbiological epidemiology of infections in cancer patients
treated in ICU
Gram-positive Gram-negative Candida
S. simulans K. pneumoniae C. glabrata
S. auricularis E. coli C. albicans
S. epidermidis Ps. aeruginosa
S. hominis A. calcoaceticus




Staphylococci isolated were all coagulase negative and oxacilline
resistant. Strains of E. coli and K. pneumoniae isolated revealed
to produce extended-spectrum b-lactamases (ESBLs) whereas
Ps.aeruginosa produced metallo-b-lactamases (MBLs). Furthrmore
all Acinetobacter isolated were multiresistant.
Conclusions: Most common pathogens were Gram-positive bacte-
ria, especially coagulase negative staphylococci, followed by en-
terobacteriaceae. Most prevalent were bloodstream infections, lo-
cal CVC-related infections and pneumonias whereas less prevalent
were urinary tract infections. Exposure of immunocompromised
patients to invasive devices in ICUs, such as multi-lumen central
venous catheters, contributes to increased rate of infections by
highly resistant pathogens (ESBL, MBL, oxacilline resistant) and
high mortality rate. Our study confirms the essential role of epi-
demiologic surveillance and infection control.
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Background and Materials: Ten year old African male diag-
nosed with acute myelogenous leukemia (AML), with a favorable
biomarker t(8;21) positive, on Childrens Oncology Group protocol
AML 0531 receiving ARA-C, Daunorubicin, Mitroxanate, Etopside,
intrathecal ARA-C, and L- asparaginase.
Methods and Results: Bacterial infections during chemotherapy
were alpha streptococcal bacteremia, VRE colonisation and Kleb-
siella bacteremia. Three months into therapy the child fell on dirt
and sustained minor asymptomatic skin abrasions over knee and
chin. Six weeks later during phase of neutropenia, presented with
painful swelling of left lower jaw with painful localised eschar over
chin and prepatellar region. Excision biopsy of cutaneous lesions
and gingival biopsy revealed fungal hyphae (see tables 1&2). As-
pergillus PCR in tissue specimen and Antigen detection in blood
were negative. Tissue biopsy was culture positive for two fungal
pathogens, Fusarium and Rhizopus. MRI of mandible was consistent
with osteomyelitis. Aggressive treatment with multiple debride-
ment procedures of the mandible, including dental extractions,
granulocyte transfusions 5 days/week, lipid formulation ampho-
tericin (10mg/kg/dose), followed by GCSF and tooth extractions
resolved the infection 16 weeks later.





Table 2. MIC of two organisms
Drug Fusarium Rhizopus
Ampho b 0.023 mcg/ml 0.5 mcg/ml
Posaconazole >32 mcg/ml >32 mcg/ml
Voriconazole 2.0 mcg/ml ND
Conclusions: He is in remission and doing well and demonstrates
a case of successful therapy despite dual posaconazole resistant
fungal infection in an immunocompromised child.
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Background: Sixteen year old Caucasian female with relapse of T-
cell acute lymphatic leukemia (ALL) for two years into Childrens
Oncology Group Protocol 434.
Materials, Methods and Results: Induction therapy of relapse
was complicated in the first week with severe anaphylaxis in-
cluding rhabdomyolysis to Bortezomib administration. Treatment
